Stellular Bio raised an undisclosed amount in Series 1 funding, led by Ziff Capital Partners, to advance STLR-201 into clinical testing for Sjogren’s disease dry eye.
Round Type
Funding Round
WatertownManufacturingBiotechnologyHealth CareTherapeuticsInvestors
Description
Stellular Bio, a Watertown, MA-based platelet-derived regenerative biologic company, raised an undisclosed amount in Series 1 funding. The round was led by Ziff Capital Partners with participation from Cockrell Interests and others. The company intends to use the funds to advance its lead candidate, STLR-201, into clinical testing for Sjogren’s disease dry eye. Led by CEO Derek Adams, Stellular Bio specializes in PRB therapy.
Quick answer
Stellular Bio raised an undisclosed amount in a Funding Round round, dated January 28, 2026. Investors: Cockrell Interests and Ziff Capital Partners. Stellular Bio is based in Watertown, Massachusetts, United States.
- How much did Stellular Bio raise?
- Stellular Bio raised an undisclosed amount in a Funding Round round on January 28, 2026.
- Who invested in Stellular Bio?
- Cockrell Interests and Ziff Capital Partners are named as investors in this round.
- What does Stellular Bio do?
- Stellular Bio is a regenerative medicine company that specializes in platelet-derived regenerative biologic (PRB) therapy.
- Where is Stellular Bio based and how big is it?
- Stellular Bio is based in Watertown, Massachusetts, United States.
Source: Fundz verified event record.
Who else raised in Therapeutics and Manufacturing around the same time
Companies in the same sectors as Stellular Bio that raised within 45 days of this round, from Fundz verified event records.
- CASI Pharmaceuticals raised $5M on December 27, 2025.
- Monteris Medical raised $28M (Series E) on March 12, 2026.
- XCath raised $30M (Series C) on March 12, 2026.
- Combat Medical raised $3.5M (Series A) on March 12, 2026.
- Electra Therapeutics raised $30M (Debt Financing) on March 11, 2026.
- Tenon Medical raised $4.3M on March 11, 2026.
Who to call at Stellular Bio, and when
A new round usually means Stellular Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Stellular Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Stellular Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Stellular Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Stellular Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Stellular Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.